Status:
COMPLETED
Desensitization and Cognitive Therapy in General Anxiety.
Lead Sponsor:
Penn State University
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Generalized Anxiety Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
This study will test the feasibility and safety of adding interpersonal and emotional processing techniques to standard cognitive behavioral therapy for generalized anxiety disorder.
Detailed Description
Generalized anxiety disorder (GAD) is characterized by chronic worry that interrupts normal functioning. Some research has shown cognitive behavioral therapy (CBT) as an effective treatment for GAD, b...
Eligibility Criteria
Inclusion
- Principal diagnosis of generalized anxiety disorder (GAD), as defined by the DSM-IV and agreed on by two diagnostic interviewers
Exclusion
- Concurrent psychosocial therapy or past adequate dosage of CBT
- Medical contributions to anxiety
- Current substance abuse, psychosis, or organic brain syndrome
Key Trial Info
Start Date :
July 1 1996
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 1998
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT00951340
Start Date
July 1 1996
End Date
December 1 1998
Last Update
September 20 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Pennsylvania State University
University Park, Pennsylvania, United States, 16802-3103